Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. A pharmaceutical industry perspective on drug labeling.
Robinson
D S
DS
Bristol-Myers Squibb Company, Wallingford, CT.
D004345:Drug Industry / Q000639:trends*; D004348:Drug Labeling / Q000331:legislation & jurisprudence / Q000639:trends*; D006801:Humans; D011619:Psychotropic Drugs; D014481:United States
D011619:Psychotropic Drugs